SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010528
Filing Date
2021-08-05
Accepted
2021-08-05 16:02:30
Documents
76
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20210630x10q.htm   iXBRL 10-Q 2071929
2 EX-10.2 kala-20210630xex10d2.htm EX-10.2 283443
3 EX-10.3 kala-20210630xex10d3.htm EX-10.3 321303
4 EX-31.1 kala-20210630xex31d1.htm EX-31.1 15223
5 EX-31.2 kala-20210630xex31d2.htm EX-31.2 15183
6 EX-32.1 kala-20210630xex32d1.htm EX-32.1 6717
7 EX-32.2 kala-20210630xex32d2.htm EX-32.2 6816
8 GRAPHIC kala-20210630xex10d3002.jpg GRAPHIC 4416
9 GRAPHIC kala-20210630xex10d3001.jpg GRAPHIC 10993
  Complete submission text file 0001558370-21-010528.txt   7773393

Data Files

Seq Description Document Type Size
10 EX-101.SCH kala-20210630.xsd EX-101.SCH 50497
11 EX-101.CAL kala-20210630_cal.xml EX-101.CAL 52947
12 EX-101.DEF kala-20210630_def.xml EX-101.DEF 145758
13 EX-101.LAB kala-20210630_lab.xml EX-101.LAB 434285
14 EX-101.PRE kala-20210630_pre.xml EX-101.PRE 300853
15 EXTRACTED XBRL INSTANCE DOCUMENT kala-20210630x10q_htm.xml XML 1176396
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 211148064
SIC: 2834 Pharmaceutical Preparations